Health Care Equipment & Services

Veeva Systems Inc. dominates cloud‑based life science software, boosting biotech efficiency and growth—stock trends, adoption, and future prospects.

IceCure Medical faces a Nasdaq $1 bid‑price notice while gearing up to release Q3 2025 results; investors watch the company’s cryo‑ablation tech and financials for a stock‑price recovery.

Investors weigh Tivic Health’s clinical promise against its stark losses—GAAP EPS –$1.97, $150k revenue, yet breakthrough nerve‑stimulation trials spark debate.

Owlet Inc. tops Q3 2025 earnings, boosts 2025 revenue outlook, and eyes Indian launch, solidifying its role in smart infant‑monitoring tech.

Discover how Niox Group PLC’s focus on asthma diagnosis and management fuels biotech innovation and drives strong investor growth.

Sonova Holding AG beats 2025/26 first‑half expectations with strong sales, AI‑driven hearing‑device growth, positioning it as a top‑performing health‑care brand.

HeartBeam Inc. reports Q3 2025 earnings: $0.9 M revenue, loss narrowed to $0.129 EPS, and guidance points to continued growth in tele‑cardiac care.

Senseonics Holdings resumes NYSE American trading after a brief suspension, restoring liquidity and investor access amid its growth in glucose‑monitoring tech.

PolyNovo Ltd’s cutting‑edge biodegradable polymers promise eco‑friendly medical solutions, driving growth for investors in Australia’s biotech sector.

GE Healthcare’s latest stock price, market cap, P/E and strategic focus reveal a cautious yet promising outlook for investors in the evolving health‑care sector.